跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle - TGA Drug Approval Details
Approvals
/
TGA
/
DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle
Approved
STANDARD
DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle
Gilead Sciences Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
Dec 9, 2025
Approval ID
4f1f4d78af4b1c15
Company
Gilead Sciences Pty Ltd
Type
Standard
Approval Details
Approval Id
4f1f4d78af4b1c15
Product Name
DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle
Artg Id
246093
Artg Name
DESCOVY 200 mg/10 mg (200 mg emtricitabine/10 mg tenofovir alafenamide) tablet bottle
Sponsor
Gilead Sciences Pty Ltd
Company Detail Path
/organization/gilead-sciences-pty-limited
Artg Date
2016-07-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/2d1b54accbdab6d9a273c4411ce04fa0.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/97b2216fd66cbc9bd3ffb8c9431f5479.pdf
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
Dec 9, 2025
Approval ID
4f1f4d78af4b1c15
Type
Standard
Back to TGA Approvals